WHO OWNS THIS?

VERIFIED OWNERSHIP RECORD

Boston Clinical Trials

Part of a larger operating group

OWNERSHIP VERDICTPE controlled

STRAIGHT ANSWER

Yes. Boston Clinical Trials is currently private-equity controlled through Alcanza Clinical Research by Martis Capital.

Sources: [1][2]

Interpretation boundary: WHO OWNS THIS? reports corporate relationships from cited public sources. Records may be incomplete, outdated, or use different ownership definitions. A relationship does not by itself show control, misconduct, legal liability, or product quality. Verify material decisions with the original source.

OWNERSHIP PATH

The layers behind the sign

  1. Business or brandBoston Clinical Trials
  2. Parent platformAlcanza Clinical Research

    Boston Clinical Trials is listed by an official source as part of Alcanza Clinical Research.

    Evidence [1]
  3. Controlling private-equity ownerMartis Capital

    Martis Capital is the verified controlling investment owner of Alcanza Clinical Research.

    Evidence [2]

PUBLIC RECORD HISTORY

What changed and when

Each version preserves SHA-256 hashes of the exact public snapshots. The ledger begins with the Release 38 baseline.

  1. baseline

    baseline snapshot

    before none · after aed872dd9d85
Open complete revision JSON